Literature DB >> 2173948

Mineral fibres, fibrosis, and asbestos bodies in lung tissue from deceased asbestos cement workers.

M Albin1, L Johansson, F D Pooley, K Jakobsson, R Attewell, R Mitha.   

Abstract

Lung tissue from 76 deceased asbestos cement workers (seven with mesothelioma) exposed to chrysotile asbestos and small amounts of amphiboles, has been studied by transmission electron microscopy, together with lung tissue from 96 controls. The exposed workers with mesothelioma had a significantly higher total content of asbestos fibre in the lungs than those without mesothelioma, who in turn, had higher concentrations than the controls (medians 189, 50, and 29 x 10(6) fibres/g (f/g]. Chrysotile was the major type of fibre. The differences were most pronounced for the amphibole fibres (62, 4.7, and 0.15 f/g), especially crocidolite (54, 1.8 and less than 0.001 f/g), but were evident also for tremolite (2.9, less than 0.001, and less than 0.001 f/g) and anthophyllite (1.7, less than 0.001, and less than 0.001 f/g). For amosite, there was no statistically significant difference between lungs from workers with and without mesothelioma; the lungs of workers had, however, higher concentrations than the controls. Strong correlations were found between duration of exposure and content of amphibole fibres in the lungs. Asbestos bodies, counted by light microscopy, were significantly correlated with the amphibole but not with the chrysotile contents. Fibrosis was correlated with the tremolite but not the chrysotile content in lungs from both exposed workers and controls. Overall, similar results were obtained using fibre counts and estimates of mass.

Entities:  

Mesh:

Substances:

Year:  1990        PMID: 2173948      PMCID: PMC1035268          DOI: 10.1136/oem.47.11.767

Source DB:  PubMed          Journal:  Br J Ind Med        ISSN: 0007-1072


  21 in total

1.  An examination of the fibrous mineral content of asbestos lung tissue from the Canadian chrysotile mining industry.

Authors:  F D Pooley
Journal:  Environ Res       Date:  1976-12       Impact factor: 6.498

2.  Quantitative assessment of inorganic fibrous particulates in dust samples with an analytical transmission electron microscope.

Authors:  F D Pooley; N J Clark
Journal:  Ann Occup Hyg       Date:  1979

3.  Lung cancer among asbestos cement workers. A Swedish cohort study and a review.

Authors:  C G Ohlson; C Hogstedt
Journal:  Br J Ind Med       Date:  1985-06

4.  Analysis of asbestos fibers and asbestos bodies in tissue samples from human lung. An international interlaboratory trial.

Authors:  B Gylseth; A Churg; J M Davis; N Johnson; A Morgan; G Mowe; A Rogers; V Roggli
Journal:  Scand J Work Environ Health       Date:  1985-04       Impact factor: 5.024

5.  Mortality among long-term employees of an Ontario asbestos-cement factory.

Authors:  M M Finkelstein
Journal:  Br J Ind Med       Date:  1983-05

6.  Exposures and mortality among chrysotile asbestos workers. Part II: mortality.

Authors:  J M Dement; R L Harris; M J Symons; C M Shy
Journal:  Am J Ind Med       Date:  1983       Impact factor: 2.214

7.  Mortality and cancer morbidity in cohorts of asbestos cement workers and referents.

Authors:  M Albin; K Jakobsson; R Attewell; L Johansson; H Welinder
Journal:  Br J Ind Med       Date:  1990-09

8.  Dust exposure and mortality in chrysotile mining, 1910-75.

Authors:  J C McDonald; F D Liddell; G W Gibbs; G E Eyssen; A D McDonald
Journal:  Br J Ind Med       Date:  1980-02

9.  Fibre type and concentration in the lungs of workers in an asbestos cement factory.

Authors:  B Gylseth; G Mowé; A Wannag
Journal:  Br J Ind Med       Date:  1983-11

10.  Dust exposure and mortality in an American chrysotile textile plant.

Authors:  A D McDonald; J S Fry; A J Woolley; J McDonald
Journal:  Br J Ind Med       Date:  1983-11
View more
  10 in total

1.  Mineral fibre analysis and routes of exposure to asbestos in the development of mesothelioma in an English region.

Authors:  D Howel; A Gibbs; L Arblaster; L Swinburne; M Schweiger; E Renvoize; P Hatton; F Pooley
Journal:  Occup Environ Med       Date:  1999-01       Impact factor: 4.402

2.  Electron microscopic microanalysis of bronchoalveolar lavage: a way to identify exposure to silica and silicate dust.

Authors:  E Monsó; A Carreres; J M Tura; J Ruiz; J Fiz; C Xaus; M Llatjós; J Morera
Journal:  Occup Environ Med       Date:  1997-08       Impact factor: 4.402

3.  Exposure and mineralogical correlates of pulmonary fibrosis in chrysotile asbestos workers.

Authors:  F H Green; R Harley; V Vallyathan; R Althouse; G Fick; J Dement; R Mitha; F Pooley
Journal:  Occup Environ Med       Date:  1997-08       Impact factor: 4.402

4.  Analysis of lung asbestos content.

Authors:  A Churg
Journal:  Br J Ind Med       Date:  1991-10

5.  Radiological changes in asbestos cement workers.

Authors:  K Jakobsson; U Strömberg; M Albin; H Welinder; L Hagmar
Journal:  Occup Environ Med       Date:  1995-01       Impact factor: 4.402

6.  Pleural mesothelioma in Sweden: an analysis of the incidence according to the use of asbestos.

Authors:  B Järvholm; A Englund; M Albin
Journal:  Occup Environ Med       Date:  1999-02       Impact factor: 4.402

7.  Mineralogical and exposure determinants of pulmonary fibrosis among Québec chrysotile miners and millers.

Authors:  Ataollah Nayebzadeh; Bruce W Case; Janick Massé; André Dufresne
Journal:  Int Arch Occup Environ Health       Date:  2005-11-09       Impact factor: 3.015

8.  Retention patterns of asbestos fibres in lung tissue among asbestos cement workers.

Authors:  M Albin; F D Pooley; U Strömberg; R Attewell; R Mitha; L Johansson; H Welinder
Journal:  Occup Environ Med       Date:  1994-03       Impact factor: 4.402

Review 9.  Persistence of natural mineral fibers in human lungs: an overview.

Authors:  A Churg; J L Wright
Journal:  Environ Health Perspect       Date:  1994-10       Impact factor: 9.031

10.  Relationship between pleural plaques and biomarkers of cumulative asbestos dose. A necropsy study.

Authors:  Pietro Gino Barbieri; Dario Consonni; Anna Somigliana
Journal:  Med Lav       Date:  2019-10-29       Impact factor: 1.275

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.